FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059380 [Registered on: 01/11/2023] Trial Registered Prospectively
Last Modified On: 19/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Correlating Diagnostic Accuracy of Clinical Features and Biomarkers to detect fungal infections in Intensive Care Unit 
Scientific Title of Study   Correlating Diagnostic Accuracy of Clinical Features and Biomarkers to detect fungal infections in Intensive Care Unit 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
GMCH/IEC/2023/1042R  Protocol Number 
GMCH/IEC/2023/208  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Naini Sood 
Designation  Post Graduate Junior Resident 
Affiliation  Government Medical College and Hospital , Sector 32 , Chandigarh 
Address  Department of Anaesthesia and Intensive Care, Block D, Level 5, GMCH, Sector 32, Chandigarh, India

Chandigarh
CHANDIGARH
160030
India 
Phone  7814052011  
Fax    
Email  nainisood9474@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swati Jindal 
Designation  Associate Professor  
Affiliation  Government Medical College and Hospital, Sector 32, Chandigarh 
Address  Department of Anaesthesia and Intensive Care, Block D, Level 5, GMCH, Sector 32, Chandigarh, India

Chandigarh
CHANDIGARH
160030
India 
Phone  9646004171  
Fax    
Email  swatirohitjindal604@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Swati Jindal 
Designation  Associate Professor  
Affiliation  Government Medical College and Hospital, Sector 32, Chandigarh 
Address  Department of Anaesthesia and Intensive Care, Block D, Level 5, GMCH, Sector 32, Chandigarh, India

Chandigarh
CHANDIGARH
160030
India 
Phone  9646004171  
Fax    
Email  swatirohitjindal604@gmail.com  
 
Source of Monetary or Material Support  
GOVERNMENT MEDICAL COLLEGE AND HOSPITAL, SECTOR -32, CHANDIGARH 
 
Primary Sponsor  
Name  Naini Sood 
Address  Department of Anaesthesia and Intensive Care, GMCH- 32, Chandigarh 
Type of Sponsor  Other [Naini Sood] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrNaini sood   GMCH- 32 CHANDIGARH  GOVERNMENT MEDICAL COLLEGE AND HOPSITAL, Sector-32, Chandigarh
Chandigarh
CHANDIGARH 
7814052011

nainisood9474@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
GMCH Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R21||Rash and other nonspecific skin eruption,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  All consecutive patients admitted to the ICU and more than or equal to 18 yrs of age will be eligible for inclusion in the study . The patients may or may not be on mechanical ventilation. 
 
ExclusionCriteria 
Details  1.Patient/family who refused to take part in the study.
2.Patient expires before the seventh day of ICU admission.
3.Patient discharged before sampling ( treatment day <7)
4.Incomplete medical record.
5. Patient on anti fungal therapy before specimen collection preceding ICU admission. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the role of CRP and PCT for predicting fungal infection in patients admitted to Intensive Care Unit.  1 week 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the role of other biomarkers like TLC, Platelet Count, IL-6,ESR and fungal cultures in predicting fungal infections in patients admitted to Intensive Care Unit.  1 year 7 months 
 
Target Sample Size   Total Sample Size="124"
Sample Size from India="124" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="26" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [nainisood9474@gmail.com].

  6. For how long will this data be available start date provided 04-11-2023 and end date provided 01-03-2025?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This is an Observational study and will be conducted in patients more than or equal to 18 yrs of age  admitted to the Intensive Care Unit. They may or may not be on mechanical ventilation.The aim of the study is to correlate clinical features and biomarkers to detect fungal infections in Intensive Care Unit. 
Close